COMMUNIQUÉS West-GlobeNewswire

-
FDA Classifies HeartWare(TM) HVAD(TM) Systems Unexpected Power Source Switching as Class I Recall
01/06/2018 -
Reata Selected to Present Early-Stage Programs at the BIO International Convention
01/06/2018 -
Agios Presents Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma and Other Solid Tumors
01/06/2018 -
OmniSeq and LabCorp Launch OmniSeq Advance℠ Assay
01/06/2018 -
Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
01/06/2018 -
ArmadaCare Sponsors Live Webinar on Creating a Talent Winning Organization with World-Renowned Business Advisor and Speaker, Ram Charan
01/06/2018 -
BioSig Technologies to Present at the 8th Annual LD Micro Invitational
01/06/2018 -
The Great Canadian Healthcare Debate
01/06/2018 -
Grand débat sur les soins de santé au Canada
01/06/2018 -
NICOX : Nulber of voting rights as of May 31, 2018
01/06/2018 -
NICOX : Nombre de droits de vote au 31 mai 2018
01/06/2018 -
Sensorion to Present at the 2018 BIO International Convention
01/06/2018 -
Bavarian Nordic to Present at Jefferies 2018 Healthcare Conference in New York City
01/06/2018 -
Celldex Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018 -
Major shareholder notification – Marathon Asset Management LLP
01/06/2018 -
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at the ASCO Annual Meeting 2018 in Chicago
01/06/2018 -
Cambrex to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018 -
ZoomMed and KDA Group Join Forces to Distribute the ZRx Prescriber in the United States
01/06/2018 -
ZoomMed et Groupe KDA unissent leurs efforts pour la distribution du Prescripteur ZRx aux États-Unis
01/06/2018
Pages